Investment supports GlobalWafers’ U.S. wafer manufacturing expansion and other strategic investments for long-term supply assurance ...

Opus Genetics, Inc. (Nasdaq: IRD) (the "Company”, "Opus Genetics” or "Opus”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients ...

Upcoming Type B Statistical Methods Meeting expected to set stage for FDA to align with EMA and MHRA on use of Fall 2026 ...

The Federal Government launches phase two of the TVET programme, enhancing skills for young Nigerians, boosting employability ...

This secular, queer friendly addiction recovery group presents July opportunities. A weekly support group meets every Monday ...

A new common application for Nevada Ready! pre-K programs is now available, giving families a single pathway to apply to more than 90 participating pre-K programs across the state. The application was ...

LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive ...

GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. Bethesda is reportedly full-steam ahead on the Fallout franchise ...

NOTE: Employees in grant funded positions are not eligible. All staff are encouraged to participate in the many Employee Development activities and events available through the University. Individual ...

Send this article to your social connections.

Detailed price information for Cartesian Therapeutics Inc (RNAC-Q) from The Globe and Mail including charting and trades.